# Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)

> **NCT05444543** · PHASE4 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 23 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Fluticasone Propionate
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT05444543
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-17
- **Primary completion:** 2023-10-13
- **Final completion:** 2023-10-13
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05444543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05444543, "Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05444543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*